Dx&Vx said it is participating in overseas research led by Coree Group on finding new biomarkers to develop therapeutics for diabetes and obesity.To search for biomarkers, Agostino Gemelli University Policlinic, an Italy-based hospital, and Coree Group are conducting a clinical study, named, "Compar
A joint team consisting of researchers from Korea University’s College of Medicine (KUCM) and the Institute of Basic Science (IBS) confirmed that a single sequence mutation in the CYFIP2 gene could cause West syndrome, a rare brain development disease.West syndrome occurs in less than six babies per
Lotte Biologics said it decided to turn to rights issues to raise 240.5 billion won ($170.2 million) to finance the acquisition of Bristol-Myers Squibb (BMS)'s Syracuse plant in the U.S and secure operating funds.Lotte Biologics, a biopharmaceutical arm under retail giant Lotte Group, plans to issue
Chong Kun Dang Pharmaceutical said Thursday it received approval for LucenBS (ingredient: ranibizumab), a biosimilar referencing Lucentis to treat wet age-related macular degeneration (AMD), from the Ministry of Food and Drug Safety.LucenBS has secured all five indications of Lucentis -- neovascular
Samsung Biologics said it signed a contract manufacturing organization (CMO) agreement worth 420 billion won ($296 million) with GlaxoSmithKline (GSK).The contract period is from Oct. 11, 2022 to Dec. 31, 2030.However, Samsung Biologics refused to disclose which drug the deal covers, as requested by
Helixmith said on Thursday that it has acquired a Russian patent for a next-generation gene therapy candidate, pMUN+VM202, to treat neuropathic pain.The investigational neuropathic pain treatment combines insulin-like growth factor (IGF-1) and hepatocyte growth factor (HGF) genes. Accordingly, pMUN
Celltrion said it signed a contract with Pinot Bio, a local bioventure, and obtained the option to implement PINOT-ADC, the latter’s antibody-drug conjugate (ADC) linker-payload platform technology.Under the agreement, Celltrion paid an upfront of 1 billion won ($701,754) and secured the right to us
3billion, a company specializing in genetic diagnostics for rare diseases, said on Tuesday that it will reveal its research results at the annual American Society of Human Genetics (ASHG) conference in Los Angeles, the U.S., from Oct. 24-28.The ASHG annual conference is the world's largest conferenc
A multinational research team including Professor Bae Hee-joon of Seoul National University Bundang Hospital (SNUBH) found that ancestry specific stroke genetic risk factors strongly predicted ischemic stroke in European, East Asian and African ancestry.Genome-wide association studies (GWASs) identi
Vaccine hesitancy is a global issue but particularly immunization among pregnant women is a controversial issue because of myths regarding vaccination safety for the mother and baby.As new bivalent Covid-19 vaccines are rolling out again nationwide, mothers should be equipped with the latest knowled
Seoul National University Bundang Hospital (SNUBH) said on Wednesday its team of researchers successfully built a renal hypoxic-reperfusion (RHR) injury model and found that combinational vitamin therapy can decrease the chances of RHR injury.Acute renal injury, which weakens kidney function due to
AriBio said Tuesday that it has filed an IND (investigational new drug) application with the U.S. Food and Drug Administration for a phase 3 clinical trial of its oral dementia treatment, AR1001.AriBio added that it is developing AR1001 as a multi-effect dementia treatment that suppresses dementia p
HK Inno.N said on Wednesday that its gastroesophageal reflux drug, K-CAB (ingredient: tegoprazan) obtained approval from the Indonesian National Agency of Drug and Food Control (NADFC) on Oct. 7, following approvals in Mongolia, China, and the Philippines.K-CAB, Korea's 30th novel drug, is a new pot
Baxter Korea said on Tuesday that it appointed Im Kwang-hyuk, former senior director of Baxter Korea’s Renal and Acute Business unit, as its new general manager, starting Oct. 1.Im joined Baxter’s Renal and Acute Business unit in 2018 and was in charge of peritoneal dialysis and hemodialysis. He was
Fujifilm Corp. said it has established an offshoot of Fujifilm Life Science in Korea to grow and accelerate the cell culture medium business on Oct. 4.Fujifilm plans to supply high-quality cell culture media for bioproduction and cell- and gene-based advanced therapeutics through Fujifilm Life Scien
Clupea, a medical big data platform company, said on Tuesday that it will jointly establish the first non-clinical big data platform based on Clinical Data Interchange Standards Consortium (CDISC) standards with the Korea Institute of Toxicology (KIT).Clupea's Medilake platform technology, which is
Aprogen has reversed its plan to acquire a cGMP plant in the United States less than a day after the initial announcement, causing repercussions.“We are examining various strategies, including the acquisition of a U.S. plant approved by the FDA, to respond to the U.S. government’s ‘made-in-America'
Severance Hospital said on Friday that its researchers have developed a mesenchymal stem cell (MSC)/anticancer virus complex carrier that improves the ability to quickly and accurately target cancer cells 100 times better than conventional carriers.The oncolytic virus penetrates into cancer cells, p
Samsung Biologics is drawing the industry’s attention by preemptively launching a CDMO (contract development and manufacturing organization) business targeting the growing market of bispecific antibody medical products.The company said Thursday that it has released “S-DUAL,” an independently develop
A team of researchers at Gangnam Severance Hospital said they discovered a pathological complete response (pCR) when administering HER2 positive breast cancer patients with a dose of carboplatin together with neoadjuvant TCHP (Taxotere +Carboplatin+Herceptin+Perjeta).HER2 benign breast cancer exhibi